Pelthos Therapeutics Inc. (PTHS)
AMEX · Common · CUSIP 171126105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PTHS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
171126105
Previous Symbol
CHRO (changed 7/2/2025)
Previous Name
Chromocell Therapeutics Corp
Business: Pelthos Therapeutics Inc. is a bio-pharmaceutical company committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens.

Company Contact

CEO
Scott M. Plesha
CFO
Frank Knuettel II
Headquarters
4400 Route 9 South, Suite 1000, Freehold, NJ 07728
Phone
877-265-8266
Investor Relations
919-908-2400 · contact@pelthos.com
SEC EDGAR Filings
View filings »